Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.
Kahan BD, Dunn J, Fitts C, Van Buren D, Wombolt D, Pollak R, Carson R, Alexander JW, Choc M, Wong R, et al. Kahan BD, et al. Among authors: pollak r. Transplantation. 1995 Feb 27;59(4):505-11. Transplantation. 1995. PMID: 7878754 Clinical Trial.
The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group.
Barone G, Chang CT, Choc MG Jr, Klein JB, Marsh CL, Meligeni JA, Min DI, Pescovitz MD, Pollak R, Pruett TL, Stinson JB, Thompson JS, Vasquez E, Waid T, Wombolt DG, Wong RL. Barone G, et al. Among authors: pollak r. Transplantation. 1996 Mar 27;61(6):875-80. doi: 10.1097/00007890-199603270-00005. Transplantation. 1996. PMID: 8623152 Clinical Trial.
The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients. The Neoral Study Group.
Barone G, Bunke CM, Choc MG Jr, Hricik DE, Jin JH, Klein JB, Marsh CL, Min DI, Pescovitz MD, Pollak R, Pruett TL, Stinson JB, Thompson JS, Vasquez E, Waid T, Wombolt DG, Wong RL. Barone G, et al. Among authors: pollak r. Transplantation. 1996 Mar 27;61(6):968-70. doi: 10.1097/00007890-199603270-00021. Transplantation. 1996. PMID: 8623168 Clinical Trial.
Safety and tolerability of cyclosporine microemulsion versus cyclosporine: two-year data in primary renal allograft recipients: a report of the Neoral Study Group.
Pescovitz MD, Barone G, Choc MG Jr, Hricik DE, Hwang DS, Jin JH, Klein JB, Marsh CL, Min DI, Pollak R, Pruett TL, Stinson JB, Thompson JS, Vasquez E, Waid T, Wombolt DG, Wong RL. Pescovitz MD, et al. Among authors: pollak r. Transplantation. 1997 Mar 15;63(5):778-80. doi: 10.1097/00007890-199703150-00027. Transplantation. 1997. PMID: 9075853 Clinical Trial.
Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation.
Roza A, Tomlanovich S, Merion R, Pollak R, Wright F, Rajagopalan P, Pruett T, Scandling J, Ryan J, Awni W, Schweitzer S, Greco R, Lam W, Nabulsi A, Hoffman R. Roza A, et al. Among authors: pollak r. Transplantation. 2002 Oct 15;74(7):1013-7. doi: 10.1097/00007890-200210150-00020. Transplantation. 2002. PMID: 12394847 Clinical Trial.
240 results